H1N1VACCINATION.US

In addition, FluMist is a live virus vaccine , and has the potential for transmission to household contacts that have a weakened immune system. Unless the potential benefit outweighs the potential risk, FluMist should not be … 500+ reports come to VAERS each week of reactions to this vaccine . silkcat51 says: May 22, 2010 at 8:45 pm. Baxter International Corporation holds the patent on the H1N1 vaccine . MedImmune, maker of FluMist, holds the patent on the H1N1 virus …

Read the original:
Cool Great Stuff | Health » DO NOT HAVE FLUMIST IF ALLERGIC TO …

… of age with recurrent wheezing because of the potential for increased risk of wheezing post vaccination unless the potential benefit outweighs the potential risk. Do not administer Influenza A ( H1N1 ) 2009 Monovalent Vaccine Live, …

Visit link:
Young Child with Asthma Given flumist – H1N1 Vaccine at School …

… of age with recurrent wheezing because of the potential for increased risk of wheezing post vaccination unless the potential benefit outweighs the potential risk. Do not administer Influenza A ( H1N1 ) 2009 Monovalent Vaccine Live, …

See the original post here:
Young Child with Asthma Given flumist – H1N1 Vaccine at School …